- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Amicas jumps on Emageon purchase opportunity
Amicas is jockeying to pick up the pieces of an acquisition gone wrong.
Amicas is jockeying to pick up the pieces of an acquisition gone wrong. Health Systems Solutions' attempt to buy Emageon failed earlier this month when adequate financing could not be found. PACS/IT vendor Amicas announced Feb. 23 that it has entered into a definitive merger agreement to pay $1.82 per share in cash for all Emageon common stock. The total, about $39 million, is much less than the ill-fated HSS bid of $62 million, but Amicas is in a better position to complete the deal than was the previous suitor. Amicas ended 2008 with cash, cash equivalents, and marketable securities of approximately $55 million and no long-term debt. The Emageon board of directors has unanimously recommended that shareholders tender their shares in the offer. Shareholders representing approximately 18% of outstanding Emageon shares have already agreed to do so.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
